Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Wanhui Shuanghe Pharmaceutical is a specialized pharmaceutical manufacturer based in China and a core subsidiary of China Resources Double Crane Pharmaceutical. The company focuses on the production of high-quality chemical drugs, particularly in the fields of cardiovascular health, endocrinology, and pediatrics. Its extensive product line includes essential generic medications such as valsartan and amlodipine, which are central to the management of chronic diseases in the Chinese market. Wanhui Shuanghe maintains advanced GMP-certified production lines and plays a vital role in the supply chain of its parent organization, China Resources Group. The company is recognized for its strong R&D capabilities in formulation development and its commitment to the consistency evaluation of generic drugs in China. It serves as a key manufacturing hub for the Double Crane brand, supporting both domestic clinical needs and international quality standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wanhui Shuanghe.